Oxidative stress and diabetic vascular complications.

Seok Man Son, Matthew K Whalin, David G Harrison, W Robert Taylor, Kathy K Griendling
Author Information
  1. Seok Man Son: Emory University School of Medicine, Division of Cardiology, 319 WMB, 1639 Pierce Drive, Atlanta, GA 30322, USA.

Abstract

Vascular complications of diabetes represent the leading cause of morbidity and mortality in affected patients. Production of reactive oxygen species is increased in diabetic patients, especially in those with poor glycemic control. Reactive oxygen species affect vascular smooth muscle cell growth and migration, endothelial function, including abnormal endothelium-dependent relaxation and expression of a proinflammatory phenotype, and modification of the extracellular matrix. All of these events contribute to the development of diabetic microvascular and macrovascular complications, suggesting that the sources of reactive oxygen species and the signaling pathways that they modify may represent important therapeutic targets.

References

  1. J Am Coll Cardiol. 1999 May;33(6):1506-11 [PMID: 10334415]
  2. Endocr Rev. 2002 Oct;23(5):599-622 [PMID: 12372842]
  3. Atherosclerosis. 1993 Aug;102(1):63-7 [PMID: 8257453]
  4. Diabetologia. 2003 Oct;46(10):1428-37 [PMID: 13680125]
  5. Nat Med. 2001 Jan;7(1):108-13 [PMID: 11135624]
  6. Arterioscler Thromb. 1992 Jun;12(6):647-56 [PMID: 1591228]
  7. Hypertension. 2003 Dec;42(6):1075-81 [PMID: 14581295]
  8. Am J Physiol Endocrinol Metab. 2001 May;280(5):E685-94 [PMID: 11287350]
  9. Circulation. 2000 Jun 6;101(22):2618-24 [PMID: 10840014]
  10. Diabetes. 2002 Feb;51(2):522-7 [PMID: 11812764]
  11. Kidney Int. 2002 Jan;61(1):186-94 [PMID: 11786100]
  12. Biofactors. 1998;7(1-2):69-76 [PMID: 9523030]
  13. Circulation. 2003 Oct 28;108(17):2034-40 [PMID: 14581381]
  14. Lancet. 1998 Sep 12;352(9131):837-53 [PMID: 9742976]
  15. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6309-13 [PMID: 1631123]
  16. Heart. 2001 Jan;85(1):87-91 [PMID: 11119472]
  17. Nature. 2001 Dec 13;414(6865):813-20 [PMID: 11742414]
  18. Science. 1996 May 3;272(5262):728-31 [PMID: 8614835]
  19. Diabetes. 2003 Mar;52(3):829-37 [PMID: 12606527]
  20. Am J Physiol. 1995 Aug;269(2 Pt 1):E239-46 [PMID: 7653541]
  21. Diabetes. 2002 May;51(5):1588-95 [PMID: 11978660]
  22. JAMA. 2002 Nov 27;288(20):2579-88 [PMID: 12444865]
  23. Circulation. 2001 Mar 27;103(12):1618-23 [PMID: 11273987]
  24. J Atheroscler Thromb. 1998;5(1):29-35 [PMID: 10077455]
  25. FEBS Lett. 1997 Nov 3;417(1):150-2 [PMID: 9395094]
  26. Diabetes Care. 2003 May;26(5):1589-96 [PMID: 12716823]
  27. Diabetologia. 2002 Apr;45(4):476-94 [PMID: 12032623]
  28. N Engl J Med. 2000 Jan 20;342(3):154-60 [PMID: 10639540]
  29. Diabetes. 2000 Nov;49(11):1939-45 [PMID: 11078463]
  30. J Clin Invest. 1995 Aug;96(2):1159-63 [PMID: 7635953]
  31. Free Radic Biol Med. 2000 Jan 1;28(1):91-101 [PMID: 10656295]
  32. Biofactors. 1999;10(2-3):157-67 [PMID: 10609877]
  33. Circ Res. 2001 Jun 22;88(12):1291-8 [PMID: 11420306]
  34. J Biol Chem. 2001 Dec 7;276(49):46142-50 [PMID: 11560925]
  35. Br J Pharmacol. 2001 Sep;134(1):21-9 [PMID: 11522593]
  36. N Engl J Med. 1993 Sep 30;329(14 ):977-86 [PMID: 8366922]
  37. Diabetes Care. 1999 Sep;22(9):1536-42 [PMID: 10480522]
  38. Diabetes. 2001 Dec;50(12):2837-41 [PMID: 11723068]
  39. N Engl J Med. 2001 Sep 20;345(12):861-9 [PMID: 11565518]
  40. J Am Coll Cardiol. 1996 Mar 1;27(3):567-74 [PMID: 8606266]
  41. Am J Cardiol. 1995 Nov 24;76(15):3E-12E [PMID: 7484885]
  42. Nutrition. 2001 Oct;17(10):888-95 [PMID: 11684397]
  43. Diabetes. 2001 Apr;50(4):851-60 [PMID: 11289052]
  44. Circ Res. 2001 Feb 2;88(2):E14-22 [PMID: 11157681]
  45. Diabetes Res Clin Pract. 1999 Sep;45(2-3):137-46 [PMID: 10588366]
  46. Nat Med. 1998 Sep;4(9):1025-31 [PMID: 9734395]
  47. Metabolism. 1995 Sep;44(9):1209-14 [PMID: 7666797]
  48. Diabetologia. 1993 Nov;36(11):1119-25 [PMID: 8270125]
  49. Diabetologia. 1994 May;37(5):449-59 [PMID: 8056181]
  50. Eur J Pharmacol. 2002 Feb 1;436(1-2):111-8 [PMID: 11834254]

Grants

  1. T32 GM008169/NIGMS NIH HHS

MeSH Term

Animals
Diabetic Angiopathies
Humans
Oxidative Stress

Word Cloud

Created with Highcharts 10.0.0complicationsoxygenspeciesdiabeticrepresentpatientsreactivevascularVasculardiabetesleadingcausemorbiditymortalityaffectedProductionincreasedespeciallypoorglycemiccontrolReactiveaffectsmoothmusclecellgrowthmigrationendothelialfunctionincludingabnormalendothelium-dependentrelaxationexpressionproinflammatoryphenotypemodificationextracellularmatrixeventscontributedevelopmentmicrovascularmacrovascularsuggestingsourcessignalingpathwaysmodifymayimportanttherapeutictargetsOxidativestress

Similar Articles

Cited By